BioIncept Coronavirus PreImplantation Factor sPIF
Synthetic PreImplantation Factor (sPIF):

Drive Cellular Repair
and Restore Damaged Tissue
in Covid-19 Patients

PreImplantation Factor (PIF)
Synthetic PreImplantation Factor (sPIF):

A Paradigm Shift In
Regenerative Medicine

Happy family
PreImplantation Factor (PIF):

A Key to Reproduction

Laboratory Experiment
Synthetic PreImplantation Factor (sPIF):

The Promise of Life-Saving
Therapeutics

Amber color vial with cap
Synthetic PreImplantation Factor (sPIF):

A Proprietary Platform

homepage-slider05-new_0
PreImplantation Factor (PIF):

A Global Research Network

BioIncept is a Pioneer in Tissue Regeneration and cellular repair

  • We have shown to regulate and stimulate self-renewal of damaged tissue across body systems, without the common challenges afflicted with cellular therapies
  • Key platform highlights include, amongst others, neuronal re-myelination (multiple sclerosis models, Nature); restoration of gastro-intestinal crypt architecture (radiation injury models, Oncotarget); reversal of muscle fibrosis (Duchenne muscular dystrophy models, Cell Death & Disease)
  • The ability to therapeutically recover and restore health of diseased tissue presents significant opportunities in regenerative therapeutics
  • Our team is hand-picked from seasoned veterans across the drug development value chain
  • Our lead product candidate is uniquely positioned to become a solution for patients on the back of in-vivo proof-of-concept data
  • We have shown proof-of-concept in animal models of several pathologies afflicted with Long Covid
  • Positive study results may be transformative for Long Covid and confirm our strategic platform potential in other disease areas